|
ES2314042T3
(es)
*
|
2001-04-17 |
2009-03-16 |
Dainippon Sumitomo Pharma Co., Ltd. |
Derivados nuevos de adenina.
|
|
NZ539064A
(en)
|
2002-09-27 |
2007-09-28 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound and use thereof
|
|
DE602004026891D1
(de)
*
|
2003-09-05 |
2010-06-10 |
Anadys Pharmaceuticals Inc |
Tlr7-liganden zur behandlung von hepatitis c
|
|
CA2559036C
(en)
|
2004-03-26 |
2013-08-20 |
Dainippon Sumitomo Pharma Co., Ltd. |
9-substituted 8-oxoadenine compound
|
|
US20090324551A1
(en)
*
|
2005-08-22 |
2009-12-31 |
The Regents Of The University Of California Office Of Technology Transfer |
Tlr agonists
|
|
WO2007093901A1
(en)
|
2006-02-17 |
2007-08-23 |
Pfizer Limited |
3 -deazapurine derivatives as tlr7 modulators
|
|
US8138172B2
(en)
|
2006-07-05 |
2012-03-20 |
Astrazeneca Ab |
8-oxoadenine derivatives acting as modulators of TLR7
|
|
TW200831105A
(en)
|
2006-12-14 |
2008-08-01 |
Astrazeneca Ab |
Novel compounds
|
|
CN101790380B
(zh)
|
2007-02-07 |
2013-07-10 |
加利福尼亚大学董事会 |
合成tlr激动剂的缀合物及其应用
|
|
EP2139894B1
(en)
|
2007-03-19 |
2011-10-26 |
AstraZeneca AB |
9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
|
|
US8067413B2
(en)
|
2007-03-19 |
2011-11-29 |
Astrazeneca Ab |
9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
|
|
US8044056B2
(en)
|
2007-03-20 |
2011-10-25 |
Dainippon Sumitomo Pharma Co., Ltd. |
Adenine compound
|
|
PE20081887A1
(es)
*
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Nuevo compuesto de adenina
|
|
EP2155743B1
(en)
|
2007-05-08 |
2012-08-29 |
AstraZeneca AB |
Imidazoquinolines with immuno-modulating properties
|
|
PE20091236A1
(es)
|
2007-11-22 |
2009-09-16 |
Astrazeneca Ab |
Derivados de pirimidina como immunomoduladores de tlr7
|
|
PE20091156A1
(es)
|
2007-12-17 |
2009-09-03 |
Astrazeneca Ab |
Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
|
|
US8865896B2
(en)
|
2008-01-17 |
2014-10-21 |
Astrazeneca Aktiebolag |
Method for preparing adenine compound
|
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
|
GB0908772D0
(en)
|
2009-05-21 |
2009-07-01 |
Astrazeneca Ab |
New salts 756
|
|
CA2760766A1
(en)
|
2009-05-21 |
2010-11-25 |
Nicholas James Bennett |
Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
|
|
PE20121091A1
(es)
|
2009-10-22 |
2012-08-17 |
Gilead Sciences Inc |
Derivados de purina o deazapurina utiles en el tratamiento de (inter alia) infecciones virales
|
|
JP6026405B2
(ja)
|
2010-04-30 |
2016-11-16 |
テロルメディクス エセアー |
リン脂質薬物類似体
|
|
US9050319B2
(en)
|
2010-04-30 |
2015-06-09 |
Telormedix, Sa |
Phospholipid drug analogs
|
|
CN103370317B
(zh)
|
2010-12-16 |
2015-10-07 |
阿斯利康(瑞典)有限公司 |
可用于治疗的咪唑并[4,5-c]喹啉-1-基衍生物
|
|
US8895570B2
(en)
|
2010-12-17 |
2014-11-25 |
Astrazeneca Ab |
Purine derivatives
|
|
WO2013172479A1
(en)
|
2012-05-18 |
2013-11-21 |
Dainippon Sumitomo Pharma Co., Ltd. |
Carboxylic acid compounds
|
|
DK3294740T3
(da)
*
|
2015-05-08 |
2019-11-04 |
H Hoffmann La Roche Ag |
Hidtil ukendte sulfonimidoylpurinonforbindelser og derivater til behandling og profylakse af virusinfektion
|
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
|
WO2018041763A1
(en)
*
|
2016-08-29 |
2018-03-08 |
F. Hoffmann-La Roche Ag |
7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection
|
|
EP3512556B1
(en)
|
2016-09-13 |
2021-08-18 |
F. Hoffmann-La Roche AG |
Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor
|
|
JP7328977B2
(ja)
*
|
2018-02-12 |
2023-08-17 |
エフ． ホフマン－ラ ロシュ アーゲー |
ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体
|
|
JP7089596B2
(ja)
*
|
2018-02-28 |
2022-06-22 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
肝がんの治療及び予防のための７位置換スルホンイミドイルプリノン化合物及び誘導体
|